Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.7/785
Registo completo
Campo DCValorIdioma
dc.contributor.authorOrmond, Louise-
dc.contributor.authorLiu, Ping-
dc.contributor.authorMatuszewski, Sebastian-
dc.contributor.authorRenzette, Nicholas-
dc.contributor.authorBank, Claudia-
dc.contributor.authorZeldovich, Konstantin-
dc.contributor.authorBolon, Daniel N.-
dc.contributor.authorKowalik, Timothy F.-
dc.contributor.authorFinberg, Robert W.-
dc.contributor.authorJensen, Jeffrey D.-
dc.contributor.authorWang, Jennifer P.-
dc.identifier.citationLouise Ormond, Ping Liu, Sebastian Matuszewski, Nicholas Renzette, Claudia Bank, Konstantin Zeldovich, Daniel N. Bolon, Timothy F. Kowalik, Robert W. Finberg, Jeffrey D. Jensen, Jennifer P. Wang; The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution, Genome Biology and Evolution, Volume 9, Issue 7, 1 July 2017, Pages 1913–1924, https://doi.org/10.1093/gbe/evx138pt_PT
dc.descriptionThis deposit is composed by the main article plus the supplementary materials of the publication.pt_PT
dc.description.abstractInfluenza virus inflicts a heavy death toll annually and resistance to existing antiviral drugs has generated interest in the development of agents with novel mechanisms of action. Favipiravir is an antiviral drug that acts by increasing the genome-wide mutation rate of influenza A virus (IAV). Potential synergistic benefits of combining oseltamivir and favipiravir have been demonstrated in animal models of influenza, but the population-level effects of combining the drugs are unknown. In order to elucidate the underlying evolutionary processes at play, we performed genome-wide sequencing of IAV experimental populations subjected to serial passaging in vitro under a combined protocol of oseltamivir and favipiravir. We describe the interplay between mutation, selection, and genetic drift that ultimately culminates in population extinction. In particular, selective sweeps around oseltamivir resistance mutations reduce genome-wide variation while deleterious mutations hitchhike to fixation given the increased mutational load generated by favipiravir. This latter effect reduces viral fitness and accelerates extinction compared with IAV populations treated with favipiravir alone, but risks spreading both established and newly emerging mutations, including possible drug resistance mutations, if transmission occurs before the viral populations are eradicated.pt_PT
dc.description.sponsorshipOffice of the Assistant Secretary of Defense for Health Affairs - Peer Reviewed Medical Research Program grant: (W81XWH-15-1-0317); Defense Advanced Research Projects Agency (DARPA) Prophecy Program; Defense Sciences Office (DSO), Contract No. HR0011-11-C-0095, and D13AP00041; MediVector; European Research Council (ERC); Fuji Films; Department of Defense.pt_PT
dc.publisherOxford University Presspt_PT
dc.subjectpopulation geneticspt_PT
dc.subjectgenetic hitchhikingpt_PT
dc.subjectmutational meltdownpt_PT
dc.titleThe Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolutionpt_PT
degois.publication.titleGenome Biology and Evolutionpt_PT
Aparece nas colecções:ED- Artigos

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Ormond_GenomeBiolEvol._2017.pdfmain article913,64 kBAdobe PDFVer/Abrir
Ormond_GenomeBiolEvol._2017-SM1.pdfsupplementary material 1245,06 kBAdobe PDFVer/Abrir
Ormond_GenomeBiolEvol._2017-SM2.xlsxsupplementary material 294,89 kBMicrosoft Excel XMLVer/Abrir

FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.